What a day at #MTC26! More than 4,400 attendees from 40+ countries came together in Boston for the largest MedTech Conference in our history. Monday’s conversations focused on the opportunities ahead for medtech and the role innovation, investment, and collaboration will play in driving growth and improving patient outcomes.
From the Bank of America Investor & Dealmaking Program to EY Pulse on MedTech, industry leaders explored where capital is flowing, the biggest opportunities in medtech for 2026-2027, and the power of innovation to drive growth and impact. Across the Medtech Campus, dozens of entrepreneurs and innovators delivered inspiring pitches, showcasing the next generation of technologies and solutions shaping the future of health care.

As AdvaMed President & CEO, Scott Whitaker said in his keynote, “A miracle is when 1 + 1 = 1,000. That’s the medtech multiplier.” The energy and ideas shared throughout the day demonstrated the extraordinary potential of what our industry can achieve together.
Live from #MTC26
Why Coming Together Matters More Than Ever in Medtech
JC Scott, AdvaMed Chief Strategy Officer
Making the Right Connections to Grow Your Medtech Business
Carmello Montalvo, CEO, Aethl Bio
Pitching the Next Big Innovation in MedTech
Irena King, Founder & CEO, SurgiCure
Why The MedTech Conference is Critical for Start-ups
Carl St. Bernard, President & CEO, Jupiter Endovascular and AdvaMed Accel Board Member


Find Your Photos
- Sign up to get notified when our photographers capture you in action! Opt-in to receive your event photos throughout the week.
- Access our MTC26 Flickr Albums here.
Overheard at #MTC26
- AdvaMed President & CEO Scott Whitaker highlights the value of medtech innovation and the need for health care policy to reflect it
- Press Release: UK regulator brings new AI and MedTech agenda to AdvaMed
- EY Pulse of Medtech Industry Report
- Brem Foundation’s post on being a key patient advocacy partner of AdvaMed
- Soum Rakshit’s, CEO and Co-Founder of MV Health, perspective on the corporate reverse pitches sessions
- Elizabeth Graham’s, CEO of Massachusetts Life Sciences Center, post on the big Massachusetts presence at #MTC26
- Operation Smile video from the Monday keynote
- Justin Bushko’s post on the exciting CEOs Unplugged sessions from today
- Sue Peschin’s post on her takeaways from today’s panel “Revolutionizing Patient Engagement: MedTech’s Direct-to-Patient Success Stories”





.png?upscale=true&width=400&upscale=true&name=Subheading%20(4).png)
.png?upscale=true&width=400&upscale=true&name=Subheading%20(6).png)
.png?upscale=true&width=400&upscale=true&name=Subheading%20(5).png)